Table II.
Name | Forward primer (5′-3′) | Reverse primer (5′-3′) |
---|---|---|
Zeb1 | GCACAACCAAGTGCAGAAG | CATTTGCAGATTGAGGCTG |
E-cadherin | GGGGTCTGTCATGGAAGGTG | CGACGTTAGCCTCGTTCTCA |
N-cadherin | CGGCCCGCTATTTGTCATCA | TGCGATTTCACCAGAAGCCT |
VEGF | GCAAAAACGAAAGCGCAAG | GGAGGCTCCAGGGCATTAGA |
TRAIL-R2 | CCACAAAGAATCAGGCATCA | CCAGGTCGTTGTGAGCTTCT |
TRAIL-R3 | GATCGTCCCATCCCCACATC | CTGCTCTGACCAAGGCTGAA |
Cyclin D1 | CCGAGGAGCTGCTGCAAATG | CGTGCGGGGTCATTGCGGC |
Bcl-2 | CTTTGAGTTCGGTGGGGTCA | GAAATCAAACAGAGGCCGC |
GAPDH | GAAGGCTGGGGCTCATTTG | AGGGGCCATCCACAGTCTTC |
All experiments were repeated at least in triplicate. mRNA expression levels were normalized to the internal reference gene GAPDH. Zeb1, zinc finger E-box-binding homeobox 1; VEGF, vascular endothelial growth factor; TRAIL-R, TNF receptor superfamily member.